ArticleAdvances in experimental medicine and biology2025
Exploring the Role of ABCA4's ECD2 Domain in Inherited Retinal Degeneration: Computational and Functional Perspectives.
Article in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The transmembrane protein ABCA4, found in the photoreceptor outer segment discs, functions to transport retinoids-a process essential to the visual transduction cycle. Variants in the ABCA4 gene, now numbering over 4000, give rise to impaired protein function, ultimately leading to various inherited retinal dystrophies (IRDs). The binding and clearance of retinoids rely on the functionality of ABCA4, and recent studies point to the role of its extracytoplasmic domain (ECD2) in retinoid binding and transport. In this study, we asked whether ABCA4 missense variants map to specific clusters within ECD2, how these residues influence retinoid interaction, and how this correlates with the 3D structure of the domain. First, ECD2 variants reported in the ClinVar database were analyzed using pathogenicity prediction tools (PolyPhen2, Provean, SIFT). Variants classified as pathogenic across all tools (PAAT) were mapped to the ECD2 domain, particularly the conserved regions or critical conserved motifs (CCMs). Most interestingly, 54% of PAAT variants are mapped to the CCMs. The convergence of these clusters in the cryo-EM structures supported the significance of the CCMs in retinoid interaction, emphasizing their relevance in understanding the pathophysiology of IRDs. Tryptophan fluorescence demonstrated that these CCM residues (specifically P1395L) were indeed crucial for retinoid interaction. By employing in silico and function-based methods, we have presented an integrated approach to delineate the functions of the ECD2 domain of ABCA4.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.